IRCT20190806044451N1招募中3 期
The effect of empagliflozin on serum erythropoietin level ,hematopoietic indices indices and the positive short term echocardiographic changes in type 2 diabetic patients with coronary artery disease
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 40 years 至 no limit（—）
- 性别
- All
入选标准
- •type2 diabetes
- •age more than 40
- •stablished cardiovascular disease with angiography
- •HbA1c between 7 to 9
排除标准
- •heart failure (EF<40 %)
- •history of myocardial infarction or un stable angina during 6 month ago
- •Recent anemia
- •severe kidney disease(GFR<30)
研究者
相似试验
招募中
不适用
Evaluation of the effect of Empagliflozin on blood glucose, BMI, HbA1c and insulin dose in patients with type 1 diabetesType 1 diabetes mellitusIRCT20130610013612N12Tabriz University of Medical Sciences60
进行中（未招募）
1 期
Dapagliflozin effect on generation of red blood cells and physical fitness in patients with type 2 diabetes - a randomized, double-blind, controlled, parallel group, exploratory studyEUCTR2017-004889-10-DEniversity Hospital Tuebingen75
招募中
3 期
Effect of empagliflozin on blood pressure, cardiovascular events, mortality and renal parametersIRCT20190911044744N3Yazd University of Medical Sciences50
招募中
3 期
Investigating the effect of empagliflozin on blood sugar control, edema, electrolytes and hypertensioIRCT20130812014333N217Kermanshah University of Medical Sciences134
招募中
不适用
Empagliflozin and Red Blood Cell 2,3-biphosphoglycerate LevelsHematocrit ChangeCardiovascular PreventionEmpagliflozinSGLT2-InhibitorsTissue OxygenationNCT06284850Aristotle University Of Thessaloniki40